Yue C P, Mann K S
Childs Nerv Syst. 1986;2(1):5-9. doi: 10.1007/BF00274025.
A prospective study was undertaken to treat all intracranial hematomas in hemophiliac A children under a uniform protocol. Patient selection was obtained by early CT scan of all hemophiliacs presenting with neurological symptoms and routine hematological screening for coagulopathies of all pediatric intracranial hematomas, spontaneous or traumatic. Nine patients, of whom seven came under category 1 and two under category 2, were entered into this study. There were eight subdural hematomas, one epidural hematoma, and one intracerebral hematoma. Surgery was required in every patient. Human factor VIII concentrate was used for replacement up to 100% just before and 3 days after surgery. Thereafter, it was maintained at 50% up to the 10th postoperative day. There was no operative or late mortality. At 6-month follow-up, eight of nine patients had recovered completely with no residual neurological deficit. We conclude that early diagnosis, prompt surgical intervention, and perfect normalization of hemostatic defect are essential in improving the outcome of these patients.
我们进行了一项前瞻性研究,按照统一方案治疗所有患血友病A的儿童颅内血肿。通过对所有出现神经症状的血友病患者进行早期CT扫描,以及对所有小儿颅内血肿(包括自发性或外伤性)进行常规血液学凝血障碍筛查来选择患者。9名患者进入本研究,其中7名属于1类,2名属于2类。有8例硬膜下血肿、1例硬膜外血肿和1例脑内血肿。每名患者均需要进行手术。在手术前及术后3天使用人凝血因子VIII浓缩剂进行替代治疗,替代率高达100%。此后,直至术后第10天维持在50%。无手术死亡或晚期死亡病例。在6个月的随访中,9名患者中有8名完全康复,无残留神经功能缺损。我们得出结论,早期诊断、及时的手术干预以及止血缺陷的完美纠正对于改善这些患者的预后至关重要。